CARRECA, Ignazio

CARRECA, Ignazio  

Discipline Chirurgiche, Oncologiche e Stomatologiche  

Mostra records
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.029 secondi).
Data di pubblicazione Titolo Autori Tipologia Autore(i) File
1-gen-2005 1. Uncommon Unresectable Advanced Ulcerative Scirrhous Carcinoma of the Nipple Destroying skin, Chest, Muscles and Ribs. Complete Remission (CR) After Epidoxorubicin (EDOX) + Gemcitabine (GEM) Weekly Administration - A Case Report CARRECA, Ignazio + 10 - Proceedings::Proceedings CARRECA I; MARCO BURGIO; SALVATORE RUSSO; DARIO PIAZZA; ANNA CIGNO; LODOVICO BALDUCCI
1-gen-2005 A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers GEBBIA, Nicolo'M. R. VALERIOARCARA, Carmelo CarloFULFARO, FabioCARRECA, Ignazio + 10 - Proceedings::Proceedings N GEBBIA; F VERDERAME; R DI LEO; D SANTANGELO; G CICERO; M R VALERIO; C ARCARA; G BADALAMENTI; F FULFARO; CARRECA I
1-gen-2015 Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo Russo, ACarreca, IDe Leo, GFirenze, A + 01 - Contributo in rivista::1.01 Articolo in rivista Russo, A; Carreca, I; Seta, C; Procaccianti, P; De Leo, G; Firenze, A; Aprea, L
1-gen-2006 An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer CARRECA, IgnazioBRONTE, Giuseppe + 10 - Proceedings::Proceedings CARRECA I; BRONTE G; BURGIO M; CARRECA A; PIAZZA D; RIZZO S; RUSSO S
1-gen-2006 Antiangiogenic effects, safety and feasibility of two different capecitabine/Oxaliplatin-based schedules in elderly colorectal cancer patients CARRECA, Ignazio + 10 - Proceedings::Proceedings CARRECA I; GIUSEPPE BRONTE; MARCO BURGIO; DARIO PIAZZA; SERGIO RIZZO; SALVATORE RUSSO; LAURA TARTAGLIA; ANNA CIGNO AND LODOVICO BALDUCCI
1-gen-2006 Antiangiogenic scheduling of lower dose chemotherapy in elderly patients with advanced colorectal cancer CARRECA, Ignazio + 10 - Proceedings::Proceedings CARRECA I; FERNANDA BELLOMO; GIUSEPPE BRONTE; DARIO PIAZZA; SERGIO RIZZO; SALVATORE RUSSO; ANNAPAOLA CARRECA AND LODOVICO BALDUCCI
1-gen-2009 Cancer chemotherapy in the older cancer patient CARRECA, Ignazio + 01 - Contributo in rivista::1.01 Articolo in rivista Carreca, I; Balducci, L
1-gen-2005 Cancer in the older person CARRECA, Ignazio + 01 - Contributo in rivista::1.01 Articolo in rivista CARRECA, I; BALDUCCI, L; EXTERMANN, M
1-gen-2005 Capecitabine (XEL) + Oxaliplatin (OX) in elderly people (EP) with Colorectal Cancer (CRC): Comparison of safety (S) and feasibility (F) of two different schedules. Preliminary findings CARRECA, IgnazioBRONTE, Giuseppe + 10 - Proceedings::Proceedings CARRECA I; S RIZZO; G BRONTE; M BURGIO; S FIORINO; G MAGGIO; A CIGNO; AP CARRECA; S RUSSO; D PIAZZA
1-gen-2010 Capecitabine (XEL) and oxaliplatin (OX) in combination with bevacizumab (BEV) in the management of elderly patients with advanced colorectal cancer (ACRC): Preliminary outcomes on safety and efficacy. CARRECA, Ignazio + 10 - Proceedings::Proceedings Carreca, i; Bellomo, f; Burgio, l; Carreca, ap; Pernice, g; Piazza, d; Russo, s; Balducci, l
1-gen-2010 Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety CARRECA, IgnazioGalvano, a + 10 - Proceedings::Proceedings Carreca, i; Amelio, r; Bellomo, f; Galvano, a; Pernice, g; Piazza, d
1-gen-2007 Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis. CARRECA, IgnazioBELLOMO, Fernanda ManuelaBRONTE, Giuseppe + 10 - Proceedings::Proceedings CARRECA I; F BELLOMO; G BRONTE; M BURGIO; A CARRECA; D PIAZZA; S RIZZO; S RUSSO; L BALDUCCI
1-gen-2013 Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? AMODEO, ValeriaBAZAN, VivianaFANALE, DanieleINSALACO, LaviniaCARUSO, StefanoCICERO, GiuseppeBRONTE, GiuseppeRUSSO, AntonioCARRECA, Ignazio + 01 - Contributo in rivista::1.01 Articolo in rivista Amodeo, V; Bazan, V; Fanale, D; Insalaco, L; Caruso, S; Cicero, G; Bronte, G; Rolfo, C; Santini, D; Russo, A
1-gen-2006 Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect? BRONTE, GiuseppeCARRECA, Ignazio + 10 - Proceedings::Proceedings S DARWISH; G BRONTE; A IGNOTO; D PIAZZA; S RIZZO; S RUSSO; CARRECA I
1-gen-2006 EMATOPOIESI E INVECCHIAMENTO CARRECA, Ignazio + 02 - Contributo in volume::2.01 Capitolo o Saggio BALDUCCI L; CARRECA I; COVA D; LORUSSO V
1-gen-2007 Founder mutations in BRCA1 and BRCA2 genes FERLA, RitaCALO', ValentinaCASCIO, SandraBADALAMENTI, GiuseppeCARRECA, IgnazioBAZAN, VivianaRUSSO, Antonio + 01 - Contributo in rivista::1.01 Articolo in rivista FERLA, R; CALO', V; CASCIO, S; RINALDI, G; BADALAMENTI, G; CARRECA, I; SURMACZ, E; COLUCCI, G; BAZAN, V; RUSSO, A
1-gen-2007 FULVESTRANT AND CAPECITABINE IN ELDERLY ADVANCED BREAST CANCER PATIENTS: THE PROPOSAL FOR AN EFFECTIVE AND SAFE COMBINED TREATMENT SCHEDULE. CARRECA, Ignazio + 10 - Proceedings::Proceedings GIUSEPPE BRONTE; FERNANDA BELLOMO; MARCO BURGIO; ANNAPAOLA CARRECA; DARIO PIAZZA; SERGIO RIZZO; SALVATORE RUSSO; CARRECA I
1-gen-2009 Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. RUSSO, AntonioFULFARO, FabioGEBBIA, Nicolo'CARRECA, Ignazio + 01 - Contributo in rivista::1.01 Articolo in rivista Russo, A; Rizzo, S; Fulfaro, F; Adamo, V; Santini, D; Vincenzi, B; Gebbia, N; Carreca, I
1-gen-2007 Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O). CARRECA, IgnazioBELLOMO, Fernanda ManuelaBRONTE, Giuseppe + 10 - Proceedings::Proceedings CARRECA I; F BELLOMO; G BRONTE; M BURGIO; D PIAZZA; S RIZZO; S RUSSO; L BALDUCCI
1-gen-2011 Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring CARRECA, Ignazio + 10 - Proceedings::Proceedings Carreca, i; Bellomo, f; Pernice, g; Antista, m; Amelio, r; Balducci, l